Lv1
40 积分 2021-12-06 加入
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
2天前
已完结
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
2天前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
10天前
已完结
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
10天前
已完结
New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria
10天前
已完结
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
12天前
已完结
Evolving therapeutic landscape of advanced hepatocellular carcinoma
12天前
已完结
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations
12天前
已完结
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
15天前
已完结
Neoplasm risk in individuals with neurofibromatosis 1 – a Danish nationwide cohort study with long-term follow-up
16天前
已关闭
皖公网安备34019202002308
